Equities

Medical System Network Co Ltd

Medical System Network Co Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Medical System Network Co Ltd grew revenues 5.30% from 109.55bn to 115.36bn while net income improved 15.58% from 1.61bn to 1.86bn.
Gross margin41.41%
Net profit margin1.04%
Operating margin2.15%
Return on assets1.80%
Return on equity7.95%
Return on investment2.86%
More ▼

Cash flow in JPYView more

In 2024, Medical System Network Co Ltd did not generate a significant amount of cash. However, the company earned 7.72bn from its operations for a Cash Flow Margin of 6.70%. In addition the company used 3.65bn on investing activities and also paid 3.94bn in financing cash flows.
Cash flow per share153.00
Price/Cash flow per share2.77
Book value per share520.24
Tangible book value per share153.27
More ▼

Balance sheet in JPYView more

Medical System Network Co Ltd has a Debt to Total Capital ratio of 62.17%, a lower figure than the previous year's 117.74%.
Current ratio0.7905
Quick ratio0.5612
Total debt/total equity1.65
Total debt/total capital0.6217
More ▼

Growth rates in JPY

SmartText is unavailable
Div yield(5 year avg)2.00%
Div growth rate (5 year)3.71%
Payout ratio (TTM)14.66%
EPS growth(5 years)32.75
EPS (TTM) vs
TTM 1 year ago
-38.23
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.